Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Tech-Powered weight loss program aims to cut cancer risk

NCT ID NCT05410353

Disease control Sponsor: University of Tennessee Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a weight loss program delivered through a patient portal (like a health app) helps overweight adults lose more weight than standard health education. About 250 participants will be randomly assigned to either the active program or a comparison group. The goal is to see if using technology can make weight loss more effective and potentially lower cancer risk.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

229 people

The number who actually took part.

Started

Feb 2023

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

16 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. are ≥ 16 years old 2. are overweight or obese (BMI ≥ 25 kg/m2) 3. have access to the Internet via the computer or use a cellphone with a data-plan access 4. are patients at one of the participating practice sites 5. are willing to accept a random assignment, and 6. are from different population groups (racial / ethnic minority, lower socioeconomic status, or reside in a rural location). Exclusion Criteria: 1. coronary or cerebrovascular disease events or vascular procedures within the past 6 months 2. certain medical conditions that put participants at high risk of adverse events or preclude exercising 3. uncontrolled psychiatric disorders 4. current substance abuse, including heavy alcohol use ≥ 5 drinks on the same occasion for ≥ 5 days in the past 30 days 5. a history of amputation or bariatric surgery or are planning to have bariatric surgery within the next 12 months 6. current weight loss medication use 7. malignancy within the last 5 years (except skin cancer) 8. plans to move out of the area during the next year 9. current participation in another clinical trial 10. pregnancy or breast feeding or are planning to become pregnant within the next 12 months, and 11. instances judged by the investigators' and primary care providers' discretion.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Behavior, health are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Health Behavior Obesity obesity disorder Overweight Weight Loss

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Behavior, health Overweight and obesity Weight loss

Contacts and locations

Locations

  • University of Tennessee Health Science Center / Department of Preventive Medicine

    Memphis, Tennessee, 38105, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.